Quilaban travelled to Munich, where it had the opportunity to closely follow the evolution of the international ecosystem in the field of Clinical Microbiology and Infectious Diseases.
Quilaban was present at ESCMID Global 2026, one of the most relevant international meetings dedicated to Clinical Microbiology and Infectious Diseases. The event, which took place in Munich between 17th and 21st April, brought together specialists, companies and sector leaders, providing a privileged environment for following the main trends and innovations in clinical diagnostics.
During the congress, the Quilaban team had the opportunity to strengthen relationships with Key Opinion Leaders (KOLs) and strategic partners, closely following the technological advances that are transforming the field. Among the highlights was the presentation of the BD BACTEC™ FXI 480/960, from partners BD/Waters, a new generation of blood culture systems that introduces significant improvements in terms of automation, operational efficiency and laboratory response capacity.
Another relevant moment was the launch of the QIAsat-Dx BCID GPF Plus AMR panel, from QIAGEN, which reinforces the response in rapid sepsis diagnosis. This solution enables the identification of Gram-positive bacteria, fungi and antimicrobial resistance markers directly from positive blood cultures, with a response time of approximately one hour, contributing to faster and more informed clinical decisions.
Quilaban’s presence at ESCMID Global 2026 reflects its effort to be at the forefront of innovation, working in close collaboration with partners and clients to drive the evolution of clinical diagnostics and contribute to better healthcare.